Annovis Bio Inc.
Organization details
- Legal name
- Annovis Bio Inc.
- Former names
- QR Pharma, Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Malvern
- Headquarters state / province
- Pennsylvania
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- ANVS
- Primary stock exchange
- NYSE
Identifiers
- SEC CIK
- 0001477845
- EIN
- 26-2540421
Board of directors
-
Claudine Bruck · DirectorSince 2023
-
Maria-Luisa Maccecchini · Director · President & CEOSince 2023
-
Mark K. White · DirectorSince 2023
-
Michael B. Hoffman · DirectorSince 2023
-
Reid McCarthy · DirectorSince 2023
Chief executives
Director election results
Annual meeting of June 17, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
89.6%
-
93.8%
-
93.8%
-
94.0%
-
94.7%
Board connections
2 of this board's directors also sit on 2 other boards. 1 is in the same sector.
-
Lantern Pharma Inc. Same sectorvia Maria-Luisa Maccecchini
- via Michael B. Hoffman
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $7,097,000
- 14 purchases by 1 insider
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 6, 2026 | Michael B. Hoffman Director | Open-market purchase | +5,000,000 | $1.00 | $5,000,000 |
| May 20, 2026 | Michael B. Hoffman Director | Open-market purchase | +2,562 | $1.75 | $4,484 |
| May 20, 2026 | Michael B. Hoffman Director | Open-market purchase | +18,849 | $1.80 | $33,928 |
| May 20, 2026 | Michael B. Hoffman Director | Open-market purchase | +54,933 | $1.90 | $104,373 |
| Apr 2, 2026 | Michael B. Hoffman Director | Open-market purchase | +713,800 | $2.10 | $1,498,980 |
| Dec 8, 2025 | Michael B. Hoffman Director | Open-market purchase | +30,000 | $4.34 | $130,200 |
| Dec 8, 2025 | Michael B. Hoffman Director | Open-market purchase | +15,000 | $4.24 | $63,600 |
| Nov 24, 2025 | Michael B. Hoffman Director | Open-market purchase | +1,489 | $4.13 | $6,150 |
| Nov 24, 2025 | Michael B. Hoffman Director | Open-market purchase | +9,200 | $3.85 | $35,420 |
| Nov 24, 2025 | Michael B. Hoffman Director | Open-market purchase | +415 | $4.14 | $1,718 |
| Nov 24, 2025 | Michael B. Hoffman Director | Open-market purchase | +28,096 | $4.15 | $116,598 |
| Nov 21, 2025 | Michael B. Hoffman Director | Open-market purchase | +10,000 | $3.49 | $34,900 |
| Nov 21, 2025 | Michael B. Hoffman Director | Open-market purchase | +10,000 | $3.50 | $35,000 |
| Nov 14, 2025 | Michael B. Hoffman Director | Open-market purchase | +15,000 | $2.11 | $31,650 |
| Oct 28, 2025 | Maria-Luisa Maccecchini Director, Officer (President & CEO) | Open-market purchase | +97,561 | $2.05 | $200,000 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Annovis Bio Inc.
Who is the CEO of Annovis Bio Inc.?
Maria-Luisa Maccecchini is Annovis Bio Inc.'s President and CEO.
How many directors are on Annovis Bio Inc.'s board?
Annovis Bio Inc.'s board has 5 directors: Claudine Bruck, Maria-Luisa Maccecchini, Mark K. White, Michael B. Hoffman and Reid McCarthy.
Are Annovis Bio Inc. insiders buying or selling shares?
Over the last 12 months, Annovis Bio Inc. insiders bought $7.1 million of shares in 14 purchases and made no open-market sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="annovis-bio-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.